MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

187

Participants

Timeline

Start Date

February 2, 2021

Primary Completion Date

June 17, 2022

Study Completion Date

December 31, 2026

Conditions
Multiple Myeloma
Interventions
DRUG

Elranatamab (PF-06863135)

BCMA-CD3 bispecific antibody

Trial Locations (89)

2020

ZNA-Middelheim, Antwerp

2060

ZNA Stuivenberg, Antwerp

2650

Universitair Ziekenhuis Antwerpen, Edegem

3002

Epworth Healthcare, East Melbourne

3004

The Alfred, Melbourne

3065

St Vincent's Hospital (Melbourne), Fitzroy

3121

Epworth Healthcare, Richmond

5530

CHU UCL Namur site Godinne, Yvoir

10021

Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care, New York

Weill Cornell Medical College - New York Presbyterian Hospital, New York

Weill Cornell Medical College - New York-Presbyterian Hospital, New York

10065

Memorial Sloan Kettering Cancer Center, New York

Weill Cornell Medical College - New York Presbyterian Hospital, New York

11101

Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy, Long Island City

14263

Roswell Park Cancer Institute, Buffalo

15706

Complejo Hospitalario Universitario de Santiago, Santiago de Compostela

19111

Fox Chase Cancer Center, Philadelphia

20246

Universitätsklinikum Hamburg - Eppendorf, Hamburg

24105

Universitätsklinik Schleswig-Holstein, Kiel

28027

Clinica Universitaria de Navarra, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

29601

St Francis Physician Services Inc, Greenville

St. Francis Hospital, Greenville

29607

Saint Francis Hospital Cancer Center, Greenville

29615

St Francis Eastside, Greenville

30308

Winship Cancer Institute @ Emory University Hospital Midtown, Atlanta

30322

Emory University Hospital, Atlanta

Emory University, Atlanta

Winship Cancer Institute, Emory University, Atlanta

30342

Blood and Marrow Transplant Group of Georgia, Atlanta

Emory Saint Joseph's Hospital, Atlanta

Northside Hospital, Atlanta

31008

Clinica Universitaria de Navarra, Pamplona

33176

Baptist Hospital of Miami, Miami

40207

Norton Cancer Institute, St. Matthews Campus, Louisville

Norton Women's and Children's Hospital, Louisville

44093

CHU de Nantes - Hôtel Dieu, Nantes

46017

Hospital Universitario Doctor Peset, Valencia

46237

Cancer Center Associates LLC, Indianapolis

Franciscan Health, Indianapolis

Indiana Blood and Marrow Transplantation, Indianapolis

52242

State University of Iowa, Iowa City

University of Iowa - Holden Comprehensive Cancer Center, Iowa City

59037

CHU de Lille - Hopital Claude Huriez, Lille

60153

Loyola University Chicago performing research at Loyola University Medical Center, Maywood

Loyola University Medical Center, Maywood

60611

Northwestern Medical Group, Chicago

Northwestern Memorial Hospital, Chicago

69120

Universitätsklinikum Heidelberg, Heidelberg

69495

Centre Hospitalier Lyon Sud - Service d'Hematologie Clinique, Pierre-Bénite

70121

Ochsner Clinic Foundation, New Orleans

75010

Hopital Saint-Louis, Paris

75012

Hôpital Saint-Antoine, Paris

75204

Baylor Scott & White Research Institute, Dallas

75246

Baylor University Medical Center, Baylor Scott & White, Dallas

Baylor University Medical Center, Dallas

86021

CHU de Poitiers, Pôle Régional de Cancérologie, Poitiers

90095

Ronald Reagan UCLA Medical Center Drug information Center, Los Angeles

The Regents of the University of California, Los Angeles

UCLA Hematology/Oncology Clinic, Los Angeles

UCLA Ronald Reagan Medical Center, Los Angeles

90211

Beverly Hills Cancer Center, Beverly Hills

92697

The Regents of the University of California, Irvine

92868

UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange

02114

Massachusetts General Hospital, Boston

08837

Hackensack University Medical Center, Edison

07601

Hackensack University Medical Center, Hackensack

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

Regional Cancer Care Associates, LLC, Hackensack

T3N 4N1

Arthur J.E. Child Comprehensive Cancer Centre, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

T6G 2C8

Alberta Health Services and The Governors of The University of Alberta, Edmonton

H1T 2M4

CIUSSS-EMTL, Installation Hopital Maisonneuve-Rosemont, Montreal

H3T 1E2

Jewish General Hospital, Montreal

H4A 3J1

McGill University Health Centre - Glen Site, Montreal

09113

Klinikum Chemnitz gGmbH, Chemnitz

467-8602

Nagoya City University Hospital, Nagoya

371-8511

Gunma University Hospital, Maebashi

650-0047

Kobe City Medical Center General Hospital, Kobe

028-3695

Iwate Medical University Hospital, Yahaba-cho

980-8574

Tohoku University Hospital, Sendai

150-8935

Japanese Red Cross Medical Center, Shibuya-ku

990-9585

Yamagata University Hospital, Yamagata

50-556

Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu, Wroclaw

85-168

Szpital Uniwersytecki nr 2 im. dr Jana Biziela w Bydgoszczy, Bydgoszcz

60-569

Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu, Poznan

08916

Institut Catala d' Oncologia. Hospital Universitari Germans Trias i Pujol, Badalona

08036

Hospital Clinic de Barcelona, Barcelona

M20 4BX

The Christie NHS Foundation Trust, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04649359 - MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb | Biotech Hunter | Biotech Hunter